Can't Miss Webinar—Lupus Nephritis: The ACR Guideline in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Opioids Commonly Prescribed for Gout Attacks

Reuters Staff  |  July 9, 2019

NEW YORK (Reuters Health)—Nearly three in 10 patients seeking care at the emergency department (ED) for acute gout will be discharged with a prescription for opioids, new research shows. “Our study suggests a high use of prescription opioid in patients discharged from the ED with a diagnosis of gout, a condition that can be managed…

Filed under:ConditionsGout and Crystalline ArthritisResearch Rheum Tagged with:Arthritis Care & ResearchEmergency DepartmentGoutopioidPainPain Management

Ankylosing Spondylitis Patients Report Improved Quality of Life with Bimekizumab

Michele B. Kaufman, PharmD, BCGP  |  July 8, 2019

Recent research shows bimekizumab may improve patient-reported outcomes and quality of life for ankylosing spondylitis (AS) patients…

Filed under:Axial SpondyloarthritisDrug UpdatesEULAR/OtherMeeting Reports Tagged with:Ankylosing SpondylitisBimekizumabEULAR

Diet & Exercise: What’s the Economic Benefit for Overweight & Obese Patients with Knee OA?

Arthritis Care & Research  |  July 1, 2019

New research recently found that, when combined with standard treatment, diet and exercise regimens are cost effective for overweight and obese patients with knee OA…

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis Care & ResearchDietExerciseKnee Osteoarthritis (OA)

Ixekizumab vs. Adalimumab for PsA: How Do They Compare?

Michele B. Kaufman, PharmD, BCGP  |  July 1, 2019

In a study of bDMARD-naive patients with active PsA and skin disease, ixekizumab proved more efficacious than adalimumab…

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsPsoriatic Arthritis Tagged with:adalimumabEULARixekizumabpsoriatic arthritis

Results for Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Lara C. Pullen, PhD  |  July 1, 2019

A study of nintedanib in patients with ILD associated with systemic sclerosis showed the treatment had only limited improvement. Although these patients had a lower rate of decline in forced vital capacity than those on placebo, nintedanib did not result in clinical benefits for other manifestations of systemic sclerosis…

Filed under:Conditions

Tanezumab’s Phase 3 Results for OA

Michele B. Kaufman, PharmD, BCGP  |  June 25, 2019

In a recent study, tanezumab proved safe and effective in the treatment of knee and hip osteoarthritis…

Filed under:AnalgesicsDrug Updates Tagged with:hipkneeKnee Osteoarthritis (OA)osteoarthritis (OA)Paintanezumab

ACR Pushes for Increased DXA Reimbursement

Linda Childers  |  June 19, 2019

Broken hips are among the most serious injuries incurred by older adults, and many fractures are preventable. According to the Centers for Disease Control and Prevention (CDC), approximately 300,000 people over the age of 65 are hospitalized each year for hip fractures, with women (who have lower bone density than men) experiencing three-quarters of all…

Filed under:Legislation & Advocacy Tagged with:Dr. Chris Phillipsdual-energy X-ray absorptiometry (DXA)DXA reimbursement cutsFractureship fractureIncreasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (S. 283)Ken Saag

Scientist Development Award Winner Probes Ethnic Disparities in Lupus

From the College  |  June 17, 2019

Recipient of a Rheumatology Research Foundation Scientist Development Award, Ashira Blazer, MD, focuses her research on racial and ethnic disparities in lupus. She looks beyond socioeconomic differences, differences in lifestyles and access to care to better understand the biologically determined differences behind disparate outcomes. With funding from the Foundation, she was able to investigate the…

Filed under:From the CollegeResearch RheumSystemic Lupus Erythematosus Tagged with:DisparitiesDr. Ashira BlazerDr. Dzifa Deyracial disparitiesRheumatology Research Foundation

Dr. Guillermo Valenzuela: Truffle Hunter, Tennis Player, Motorcycle Tourist

Carol Patton  |  June 17, 2019

Some would call Guillermo J. Valenzuela, MD, a hunter of sorts. He has accompanied men and their dogs into the forests of Italy in search of white truffles, an underground fungus considered a European delicacy. “Years ago, when visiting my wife’s family in Italy, I walked into a very old restaurant in Parma,” says Dr….

Filed under:ProfilesRheum After 5 Tagged with:Dr. Guillermo Valenzuela

Advanced Practice Providers Should Learn Musculoskeletal Ultrasound

Heather Benham, DNP, RN, CPNP, RhMSUS, on behalf of the ARP Practice Committee   |  June 17, 2019

I have worked as an advanced practice provider (APP) in pediatric rheumatology for nearly 16 years. My collaborating physicians have allowed me to function to the full extent of my scope of practice while allowing me to develop professionally within the subspecialty. My latest endeavor has been learning how to perform musculoskeletal ultrasound (MSUS) and…

Filed under:ConditionsPractice Support Tagged with:Advanced Practice CliniciansMusculoskeletal UltrasoundUltrasound

  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 331
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences